The Challenge:

The patient's main concern was to reduce chronic inflammation around tooth #8 and #9. The patient previously had received treatment at a general dentist and a periodontist without significant improvement.

The Background:

• Age: 28
• Sex: F
• Medical History: Patient stated that she is in good overall health.
• Family History: Breast and renal cancer, cardiovascular disease, high blood pressure and heart attack, type 2 diabetes, and Alzheimer’s disease
• Last Dental Exam: 12/05/2018
• Home Care: Brushing twice daily with Tom's of Maine toothpaste and a Sonicare power toothbrush, and Crest^® ProHealth^™ rinse with occasional flossing.
• Chief Complaint: This area (maxillary anterior) has been addressed by various providers with no improvement.
• Periodontal Assessment: Generalized inflammation and bleeding with 3-6mm periodontal pockets, moderate subgingival calculus, and light generalized plaque. Radiographs revealed horizontal and vertical bone loss while the bacterial slide showed various organisms.

The Solution:

• Date of MyPerioPath^® (Pre-Therapy) and Celsus One^™ Tests: 7/20/2020
• Periodontal Therapy: Two back-to-back appointments consisted of full mouth debridement, full mouth scaling and root planing (SRP), periodontal charting, Triology^® serum, and full mouth ozone. Concluded therapy following 6 weeks of healing.
• Systemic Antibiotic Used: Considered but not administered.
• Home Care: To the existing home care added the Viajet oral irrigator, Perioscript^™ twice a day in the water irrigator, smart floss daily, copper tongue cleaner, Triology rinse and Olive Gold 03^® (ozonated olive oil).
• Date of MyPerioProgress^® (Post-Therapy) Test: 9/1/2020

The Result:

Upon assessment at the follow-up appointment, the pocket depth reduction and bleeding were reduced significantly and the interdental papilla between tooth #8 and #9 showed great improvement. Overall, the patient expressed enormous satisfaction with this resolution. The therapy produced a 9% overall reduction of the pathogens which was measured by MyPerioProgress results.  With the minimal reduction of bacteria, but significant resolution of clinical signs, the emphasis is placed on the home care regimen and regular maintenance visit. Celsus One shows a minimal risk of relapse due to her own inflammatory response. The goal is to be able to establish home care habits to assist the patient's remission and reinforce the need for recall, not just for oral health, but overall wellbeing.

About the Author: